Radiation synovectomy with 90Y colloid in the therapy of recurrent knee joint effusions in patients with inflammatory joint diseases

被引:16
|
作者
Chrapko, Beata
Zwolak, Robert
Nocun, Anna
Golebiewska, Renata
Majdan, Maria
机构
[1] Skubiszewski Med Univ Lublin, Chair & Dept Nucl Med, PL-20090 Lublin, Poland
[2] Skubiszewski Med Univ Lublin, Chair & Dept Rheumatol & Connect Tissue Dis, PL-20090 Lublin, Poland
关键词
isotopic radiation synovectomy; knee joint effusion; chronic inflammatory joint diseases;
D O I
10.1007/s00296-006-0283-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to assess the effectiveness of radiation synovectomy (RSV) in the treatment of recurrent joint effusions, using Y-90 in patients with chosen inflammatory joint diseases. The group of treated patients consisted of 30 people. Qualification for the treatment was based on clinical assessment, three-phase bone scintigraphy (BS3) and biochemical analysis. Intra-articular injection of Y-90 was performed. Biochemical analysis was repeated after 48 h, 4 and 24 weeks, whereas BS3 was repeated after 24 weeks. Changes in the second phase of BS3 were assessed visually, using a four-degree scale and in the third phase, semiquantitatively with J/B ratio. The changes in the blood pool phase before RSV were 3.4 +/- 0.6 and after the therapy 2.00 +/- 0.8 (P < 0.001). The J/B ratio was: before RSV 2.58 +/- 08; after treatment 2.09 +/- 0.9 (P < 0.05). RSV is an effective method to treat recurrent effusions in patients with RA and SPA.
引用
收藏
页码:729 / 734
页数:6
相关论文
共 48 条
  • [41] IMMUNOHISTOPATHOLOGIC FINDINGS IN SYNOVIAL BIOPSIES BEFORE AND AFTER SYNOVECTOMY IN PATIENTS WITH CHRONIC INFLAMMATORY JOINT DISEASES AND THEIR RELATION TO CLINICAL-EVALUATION - A PROSPECTIVE STUDY OF BIOPSIES TAKEN FROM AREAS SELECTED BY ARTHROSCOPY
    PAUS, AC
    MELLBYE, OJ
    FORRE, O
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1990, 19 (04) : 269 - 279
  • [42] The prognostic value of functional tumor volume and total lesion glycolysis in patients with colorectal cancer liver metastases undergoing 90Y selective internal radiation therapy plus chemotherapy
    Gulec, Seza A.
    Suthar, Rekha R.
    Barot, Tushar C.
    Pennington, Kenneth
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (07) : 1289 - 1295
  • [43] The prognostic value of functional tumor volume and total lesion glycolysis in patients with colorectal cancer liver metastases undergoing 90Y selective internal radiation therapy plus chemotherapy
    Seza A. Gulec
    Rekha R. Suthar
    Tushar C. Barot
    Kenneth Pennington
    European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 : 1289 - 1295
  • [44] IMMO-LDRT01: Immunophenotyping of patients suffering from chronic degenerative joint diseases and receiving local low-dose radiation therapy
    Harrer, A.
    Ruehle, P. F.
    Gryc, T.
    Ott, O. J.
    Fietkau, R.
    Gaipl, U. S.
    Frey, B.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 : S25 - S25
  • [45] Safety analysis of regorafenib prior to selective internal radiation therapy (SIRT) using 90Y resin microspheres for the treatment (tx) of patients (pts) with refractory metastatic colorectal cancer (mCRC) with liver metastases (mets).
    Kennedy, Andrew S.
    Shipley, Dianna
    Blakely, L. Johnetta
    Hemphill, Michael Brian
    Shih, Kent C.
    Mainwaring, Mark G.
    Peyton, James D.
    Zubkus, John D.
    Wright, David Donald
    Bendell, Johanna C.
    Singh, Jaswinder
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [46] Proteome analysis reveals disease-associated marker proteins to differentiate RA patients from other inflammatory joint diseases with the potential to monitor anti-TNFα therapy
    Drynda, S
    Ringel, B
    Kekow, M
    Kühne, C
    Drynda, A
    Glocker, MO
    Thiesen, HJ
    Kekow, J
    PATHOLOGY RESEARCH AND PRACTICE, 2004, 200 (02) : 165 - 171
  • [47] Launching of the IMMO-LDRT01 study: immunophenotyping from blood of patients suffering from chronic degenerating joint diseases and receiving local low dose radiation therapy (LDRT)
    Harrer, A.
    Ruehle, P. F.
    Ott, O. J.
    Gryc, T.
    Fietkau, R.
    Gaipl, U. S.
    Frey, B.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 : 140 - 140
  • [48] Patients with Spondyloarthritis and obesity who fail TNF antagonist therapy: Change the subcutaneous injection site before the biologic? Comment on: "Impact of obesity on the efficacy of different biologic agents in inflammatory diseases: A systematic review and meta-analysis" by Shan et al. Joint Bone Spine, 2019, 86, 173-183
    Brocq, Olivier
    Acquacalda, Emilie
    Florent, Amelie
    Lascar, Tristan
    JOINT BONE SPINE, 2020, 87 (01) : 103 - 104